124 related articles for article (PubMed ID: 34589990)
1. Identification of Novel
Ou SI; Xiu J; Nagasaka M; Xia B; Zhang SS; Zhang Q; Swensen JJ; Spetzler D; Korn WM; Zhu VW; Liu SV
JTO Clin Res Rep; 2021 Feb; 2(2):100132. PubMed ID: 34589990
[TBL] [Abstract][Full Text] [Related]
2. NRG1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis.
Nagasaka M; Ou SI
Trends Cancer; 2022 Mar; 8(3):242-258. PubMed ID: 34996744
[TBL] [Abstract][Full Text] [Related]
3. NRG1 and NRG2 fusions in non-small cell lung cancer (NSCLC): seven years between lights and shadows.
Trombetta D; Sparaneo A; Fabrizio FP; Di Micco CM; Rossi A; Muscarella LA
Expert Opin Ther Targets; 2021 Oct; 25(10):865-875. PubMed ID: 34706602
[TBL] [Abstract][Full Text] [Related]
4. Expert Consensus on the Diagnosis and Treatment of
Xu C; Wang Q; Wang D; Wang W; Fang W; Li Z; Liu A; Yu J; Zhong W; Wang Z; Zhang Y; Liu J; Zhang S; Cai X; Liu A; Li W; Zhan P; Liu H; Lv T; Miao L; Min L; Chen Y; Yuan J; Wang F; Jiang Z; Lin G; Huang L; Pu X; Lin R; Liu W; Rao C; Lv D; Yu Z; Li X; Tang C; Zhou C; Zhang J; Xue J; Guo H; Chu Q; Meng R; Wu J; Zhang R; Zhou J; Zhu Z; Li Y; Qiu H; Xia F; Lu Y; Chen X; Ge R; Dai E; Han Y; Pan W; Pang F; He Q; Huang J; Wang K; Wu F; Xu B; Wang L; Zhu Y; Lin L; Xie Y; Lin X; Cai J; Xu L; Li J; Jiao X; Li K; Wei J; Feng H; Wang L; Du Y; Yao W; Shi X; Niu X; Yuan D; Yao Y; Huang J; Feng Y; Zhang Y; Sun P; Wang H; Ye M; Wang Z; Hao Y; Wang Z; Wan B; Lv D; Yang S; Kang J; Zhang J; Zhang C; Ou J; Shi L; Wang Y; Li B; Zhang Z; Li Z; Liu Z; Yang N; Wu L; Wang H; Jin G; Wang G; Wang J; Fang M; Fang Y; Li Y; Wang X; Zhang Y; Zhu X; Shen Y; Ma S; Wang B; Si L; Song Y; Lu Y; Chen J; Song Z
Glob Med Genet; 2024 Jan; 11(1):86-99. PubMed ID: 38414979
[TBL] [Abstract][Full Text] [Related]
5. Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset.
Nagasaka M; Brazel D; Baca Y; Xiu J; Al-Hallak MN; Kim C; Nieva J; Swensen JJ; Spetzler D; Korn WM; Socinski MA; Raez LE; Halmos B; Ou SI
Transl Oncol; 2023 Oct; 36():101744. PubMed ID: 37516008
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes.
Chang JC; Offin M; Falcon C; Brown D; Houck-Loomis BR; Meng F; Rudneva VA; Won HH; Amir S; Montecalvo J; Desmeules P; Kadota K; Adusumilli PS; Rusch VW; Teed S; Sabari JK; Benayed R; Nafa K; Borsu L; Li BT; Schram AM; Arcila ME; Travis WD; Ladanyi M; Drilon A; Rekhtman N
Clin Cancer Res; 2021 Jul; 27(14):4066-4076. PubMed ID: 33947695
[TBL] [Abstract][Full Text] [Related]
7. RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers.
Severson E; Achyut BR; Nesline M; Pabla S; Previs RA; Kannan G; Chenn A; Zhang S; Klein R; Conroy J; Sausen M; Sathyan P; Saini KS; Ghosh A; Jensen TJ; Reddy P; Ramkissoon SH
J Mol Diagn; 2023 Jul; 25(7):454-466. PubMed ID: 37164276
[TBL] [Abstract][Full Text] [Related]
8. Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
Ptáková N; Martínek P; Holubec L; Janovský V; Vančurová J; Grossmann P; Navarro PA; Rodriguez Moreno JF; Alaghehbandan R; Hes O; Májek O; Pešek M; Michal M; Ondič O
Genes Chromosomes Cancer; 2021 Jul; 60(7):474-481. PubMed ID: 33583086
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Characteristics of NRG1 Fusion-Positive Solid Tumors in Korean Patients.
Cha YJ; Lee C; Joo B; Kim KA; Lee CK; Shim HS
Cancer Res Treat; 2023 Oct; 55(4):1087-1095. PubMed ID: 37321274
[TBL] [Abstract][Full Text] [Related]
10. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
[TBL] [Abstract][Full Text] [Related]
11. Detection of NRG1 Gene Fusions in Solid Tumors.
Jonna S; Feldman RA; Swensen J; Gatalica Z; Korn WM; Borghaei H; Ma PC; Nieva JJ; Spira AI; Vanderwalde AM; Wozniak AJ; Kim ES; Liu SV
Clin Cancer Res; 2019 Aug; 25(16):4966-4972. PubMed ID: 30988082
[TBL] [Abstract][Full Text] [Related]
12. Identification of Novel CD74-NRG2α Fusion From Comprehensive Profiling of Lung Adenocarcinoma in Japanese Never or Light Smokers.
Kohsaka S; Hayashi T; Nagano M; Ueno T; Kojima S; Kawazu M; Shiraishi Y; Kishikawa S; Suehara Y; Takahashi F; Takahashi K; Suzuki K; Takamochi K; Mano H
J Thorac Oncol; 2020 Jun; 15(6):948-961. PubMed ID: 32036070
[TBL] [Abstract][Full Text] [Related]
13.
Ross JS; Ali SM; Fasan O; Block J; Pal S; Elvin JA; Schrock AB; Suh J; Nozad S; Kim S; Jeong Lee H; Sheehan CE; Jones DM; Vergilio JA; Ramkissoon S; Severson E; Daniel S; Fabrizio D; Frampton G; Miller VA; Stephens PJ; Gay LM
Oncologist; 2017 Dec; 22(12):1444-1450. PubMed ID: 29079636
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions.
Darabi S; Elliott A; Braxton DR; Zeng J; Hodges K; Poorman K; Swensen J; Shanthappa BU; Hinton JP; Gibney GT; Moser J; Phung T; Atkins MB; In GK; Korn WM; Eisenberg BL; Demeure MJ
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326655
[TBL] [Abstract][Full Text] [Related]
15. Inter-conversion of neuregulin2 full and partial agonists for ErbB4.
Wilson KJ; Mill CP; Cameron EM; Hobbs SS; Hammer RP; Riese DJ
Biochem Biophys Res Commun; 2007 Dec; 364(2):351-7. PubMed ID: 17945187
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the repressors Nrg1 and Nrg2 with the Snf1 protein kinase in Saccharomyces cerevisiae.
Vyas VK; Kuchin S; Carlson M
Genetics; 2001 Jun; 158(2):563-72. PubMed ID: 11404322
[TBL] [Abstract][Full Text] [Related]
17. Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.
Cohen D; Hondelink LM; Solleveld-Westerink N; Uljee SM; Ruano D; Cleton-Jansen AM; von der Thüsen JH; Ramai SRS; Postmus PE; Graadt van Roggen JF; Hoppe BPC; Clahsen PC; Maas KW; Ahsmann EJM; Ten Heuvel A; Smedts F; van Rossem RN; van Wezel T
J Thorac Oncol; 2020 Jun; 15(6):1000-1014. PubMed ID: 32014610
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases.
Huang RSP; Haberberger J; Sokol E; Schrock AB; Danziger N; Madison R; Trabucco S; Jin D; Pavlick D; Ramanan V; Hole K; McGregor K; Venstrom J; Ross JS
Int J Cancer; 2021 Apr; 148(7):1778-1788. PubMed ID: 33336398
[TBL] [Abstract][Full Text] [Related]
19. CD74-NRG1 fusions in lung adenocarcinoma.
Fernandez-Cuesta L; Plenker D; Osada H; Sun R; Menon R; Leenders F; Ortiz-Cuaran S; Peifer M; Bos M; Daßler J; Malchers F; Schöttle J; Vogel W; Dahmen I; Koker M; Ullrich RT; Wright GM; Russell PA; Wainer Z; Solomon B; Brambilla E; Nagy-Mignotte H; Moro-Sibilot D; Brambilla CG; Lantuejoul S; Altmüller J; Becker C; Nürnberg P; Heuckmann JM; Stoelben E; Petersen I; Clement JH; Sänger J; Muscarella LA; la Torre A; Fazio VM; Lahortiga I; Perera T; Ogata S; Parade M; Brehmer D; Vingron M; Heukamp LC; Buettner R; Zander T; Wolf J; Perner S; Ansén S; Haas SA; Yatabe Y; Thomas RK
Cancer Discov; 2014 Apr; 4(4):415-22. PubMed ID: 24469108
[TBL] [Abstract][Full Text] [Related]
20. Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers.
Tao Z; Liu J; Li T; Xu H; Chen K; Zhang J; Zhou H; Sun J; Han J; Guo Z; Yang H; Cao WM; Hu X
Front Oncol; 2021; 11():741142. PubMed ID: 34650924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]